Newsletter Subject

Lawmakers Take Up Fallout From Change Healthcare Cyberattack

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Apr 16, 2024 10:45 PM

Email Preheader Text

Daily Headlines Tuesday, April 16, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Tuesday, April 16, 2024 Today's Top Stories for {NAME} [PRACTICE MANAGEMENT]( [Lawmakers Take Up Fallout From Change Healthcare Cyberattack]( [PERSPECTIVES]( [The H5N1 Outbreak Is Not a Test Run, It's a Warning Shot]( [INFECTIOUS DISEASE]( [Only One Harm From mRNA COVID Vaccines, Report Determines]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Uncovering the Under-Diagnosed in MDS: The MDS Diagnostic Accelerator Hub]( [PUBLIC HEALTH & POLICY]( [Improper Payments in Medicare and Medicaid: Who's at Fault?]( [MEETING COVERAGE]( [Possible Pulmonary Benefit With Viltolarsen for Duchenne Muscular Dystrophy]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [The California Saga: Why Some DOs Fear Combined Medical Boards]( CME SPOTLIGHT [Optimizing Anemia Management in Patients With Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia Through Shared Decision-Making]( [SPECIAL REPORTS]( [Should DOs and MDs Have Separate Licensing Boards? They Still Do in 13 States]( [OB/GYN]( [Can Testosterone Aid Women's Menopausal Symptoms?]( [ENDOCRINOLOGY]( [Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Amplifying New and Emerging Clinical Evidence in the Treatment and Management of Myelodysplastic Syndrome]( [INFECTIOUS DISEASE]( [Novel Chlamydia Vaccine Shows Promise in Early Trial]( [CARDIOLOGY]( [FDA Advisors' COIs; Ongoing Ukraine Heart Transplants; N.J. Cardiologist's $2M Fraud]( [GASTROENTEROLOGY]( [TNF Inhibitors for IBD Linked to Kidney Function Declines]( CME SPOTLIGHT [Beyond Transfusions: New and Emerging Therapies for Beta Thalassemia]( [ONCOLOGY/HEMATOLOGY]( [Roundup Maker Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer]( [INFECTIOUS DISEASE]( [White House Announces Partnership With 50 Countries to Stifle Future Pandemics]( [PUBLIC HEALTH & POLICY]( [Counterfeit 'Botox' Spreading Across the U.S., CDC Warns]( CME SPOTLIGHT [Individualizing Advanced/Metastatic HER2+ Breast Cancer Care: Evidence-Based and Patient-Centered Approaches]( [PUBLIC HEALTH & POLICY]( [The 340B Program Isn't Going Anywhere, Lawmaker Tells Hospital Executives]( [ONCOLOGY/HEMATOLOGY]( [Automated, Personalized Outreach Boosts CRC Screening in Diverse Patient Population]( [MEETING COVERAGE]( [Algorithm Predicts Disability From Point-of-Care EEGs]( CME SPOTLIGHT [Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes]( [ASCO READING ROOM]( [Isabelle Bedrosian, MD, on Germline Testing for Patients With Breast Cancer]( [ASCO READING ROOM]( [New Breast Cancer Germline Testing Guideline Expands on Earlier Recommendations]( [ONCOLOGY/HEMATOLOGY]( [Many With Breast Cancer 'Systematically Left Behind,' Report Says]( # Weekly Survey [More Evidence Needed for Youth Gender Care?]( A major review in the United Kingdom [found weak evidence]( for puberty blockers and hormones in youth gender care[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-04-16&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

06/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.